Puretech Health PLC - ADRPRTCY
13F holders, Q2 2024 (June 30)6holders +2
3new positions
1sold out
$3.74avg. 13F price*
At the end of Q2 2024, 6 institutions reported holding Puretech Health PLC - ADR (PRTCY) in their 13F filings, up 2 from Q1 2024. 3 opened new positions and 1 sold out. The largest holders were Birch Hill Investment Advisors LLC ($702K), Pentwater Capital Management LP ($405K) and Morgan Stanley ($71K).
- Company
- Puretech Health PLC - ADR
- CUSIP
- 746237106
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $790K |
| Exits | 1 | $197K |
All 13F filers, Q1 2024 → Q2 2024: 305,858 shares bought and 7,771 shares sold, net +298,087 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Birch Hill Investment Advisors LLC | 0.03% | New | 302,000 | $702K |
| Pentwater Capital Management LP | 0.01% | Reduce -4.8% | 16,193 | $405K |
| Morgan Stanley | 0.00% | New | 2,827 | $71K |
| ADAR1 Capital Management, LLC | 0.00% | New | 700 | $18K |
| UBS Group AG | 0.00% | Add +1655.0% | 351 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -46.7% | 73 | $2K |
"% of holder's portfolio" is PRTCY's weight in each manager's 13F, not the share of Puretech Health PLC - ADR the manager owns.